HIV-1 Specific CD4 Responses in Primary HIV-1 Infection predict disease progression in the SPARTAC Trial
Objectives Immune factors determining clinical progression following HIV-1 infection remain unclear. The SPARTAC trial randomised 366 participants in primary HIV infection (PHI) to different short course therapies. The aim of this study was to investigate how early immune responses in PHI impacted c...
Main Authors: | Frater, A, Ewings, F, Hurst, J, Brown, H, Robinson, N, Fidler, S, Babiker, A, Weber, J, Porter, K, Phillips, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wolters Kluwer
2013
|
Similar Items
-
Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection
by: Hoffmann, M, et al.
Published: (2016) -
HIV-1 drug resistance in primary infections in the UK.
by: Fidler, S, et al.
Published: (2001) -
Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection.
by: Fox, J, et al.
Published: (2008) -
Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection.
by: Oxenius, A, et al.
Published: (2001) -
Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.
by: Hamlyn, E, et al.
Published: (2012)